Skip to main content
Applied Microbiology logoLink to Applied Microbiology
. 1967 Jul;15(4):916–920. doi: 10.1128/am.15.4.916-920.1967

Stability of Rubella Complement-fixing Antigens

Nathalie J Schmidt 1, Edwin H Lennette 1
PMCID: PMC547095  PMID: 6049308

Abstract

Various types of rubella complement-fixing (CF) antigen preparations derived from infected BHK-21 cell cultures were examined for stability to certain chemical and physical agents. Antigens studied included: infected culture fluids concentrated 100-fold, ether-treated fluid concentrates, alkaline buffer extracts of infected cells, and large- and small-particle CF antigens separated by Sephadex gel filtration. All preparations were stable at -20 C for months, and were unaffected by three cycles of freezing and thawing. Ether treatment rendered antigens highly susceptible to thermal inactivation at 56 C; untreated antigens were inactivated slowly and showed a persistent fraction of activity even after 2 hr. Large-particle antigen was found to be slightly more susceptible than small-particle antigen to thermal inactivation and ether treatment. CF activity in alkaline buffer extracts was more labile than that in untreated or ether-treated fluid concentrates upon dialysis, Sephadex gel filtration, and sucrose density gradient centrifugation.

Full text

PDF
916

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fabiyi A., Sever J. L., Ratner N., Caplan B. Rubella virus: growth characteristics and stability of infectious virus and complement-fixing antigen. Proc Soc Exp Biol Med. 1966 Jun;122(2):392–396. doi: 10.3181/00379727-122-31143. [DOI] [PubMed] [Google Scholar]
  2. MACPHERSON I., STOKER M. Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence. Virology. 1962 Feb;16:147–151. doi: 10.1016/0042-6822(62)90290-8. [DOI] [PubMed] [Google Scholar]
  3. Schell K., Wong K. T. Stability and storage of rubella complement fixing antigen. Nature. 1966 Nov 5;212(5062):621–622. doi: 10.1038/212621a0. [DOI] [PubMed] [Google Scholar]
  4. Schell K., Wong K. T., Turner H. C., Huebner R. J. Production of rubella complement fixing antigen in BHK-21 cells. Proc Soc Exp Biol Med. 1966 Dec;123(3):832–836. doi: 10.3181/00379727-123-31617. [DOI] [PubMed] [Google Scholar]
  5. Schmidt N. J., Lennette E. H., Gee P. S. Demonstration of rubella complement-fixing antigens of two distinct particle sizes by gel filtration on sephadex G-200. Proc Soc Exp Biol Med. 1966 Dec;123(3):758–762. doi: 10.3181/00379727-123-31596. [DOI] [PubMed] [Google Scholar]
  6. Schmidt N. J., Lennette E. H. Rubella complement-fixing antigens derived from the fluid and cellular phases of infected BHK-21 cells: extraction of cell-associated antigen with alkaline buffers. J Immunol. 1966 Dec;97(6):815–821. [PubMed] [Google Scholar]
  7. Schmidt N. J., Lennette E. H. The complement-fixing antigen of rubella virus. Proc Soc Exp Biol Med. 1966 Jan;121(1):243–250. doi: 10.3181/00379727-121-30748. [DOI] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES